• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RGD肽细胞表面展示增强减毒沙门氏菌介导的癌症治疗的靶向性和治疗效果。

RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy.

作者信息

Park Seung-Hwan, Zheng Jin Hai, Nguyen Vu Hong, Jiang Sheng-Nan, Kim Dong-Yeon, Szardenings Michael, Min Jung Hyun, Hong Yeongjin, Choy Hyon E, Min Jung-Joon

机构信息

1. Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea;; 6. Biological Resource Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup, Republic of Korea.

1. Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea;

出版信息

Theranostics. 2016 Jun 20;6(10):1672-82. doi: 10.7150/thno.16135. eCollection 2016.

DOI:10.7150/thno.16135
PMID:27446500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4955065/
Abstract

Bacteria-based anticancer therapies aim to overcome the limitations of current cancer therapy by actively targeting and efficiently removing cancer. To achieve this goal, new approaches that target and maintain bacterial drugs at sufficient concentrations during the therapeutic window are essential. Here, we examined the tumor tropism of attenuated Salmonella typhimurium displaying the RGD peptide sequence (ACDCRGDCFCG) on the external loop of outer membrane protein A (OmpA). RGD-displaying Salmonella strongly bound to cancer cells overexpressing αvβ3, but weakly bound to αvβ3-negative cancer cells, suggesting the feasibility of displaying a preferential homing peptide on the bacterial surface. In vivo studies revealed that RGD-displaying Salmonellae showed strong targeting efficiency, resulting in the regression in αvβ3-overexpressing cancer xenografts, and prolonged survival of mouse models of human breast cancer (MDA-MB-231) and human melanoma (MDA-MB-435). Thus, surface engineering of Salmonellae to display RGD peptides increases both their targeting efficiency and therapeutic effect.

摘要

基于细菌的抗癌疗法旨在通过主动靶向并有效清除癌症来克服当前癌症治疗的局限性。为实现这一目标,在治疗窗口期间靶向并维持细菌药物处于足够浓度的新方法至关重要。在此,我们研究了在外膜蛋白A(OmpA)外环展示RGD肽序列(ACDCRGDCFCG)的减毒鼠伤寒沙门氏菌的肿瘤嗜性。展示RGD的沙门氏菌与过表达αvβ3的癌细胞强烈结合,但与αvβ3阴性癌细胞结合较弱,这表明在细菌表面展示优先归巢肽的可行性。体内研究表明,展示RGD的沙门氏菌显示出强大的靶向效率,导致过表达αvβ3的癌症异种移植瘤消退,并延长了人乳腺癌(MDA-MB-231)和人黑色素瘤(MDA-MB-435)小鼠模型的生存期。因此,对沙门氏菌进行表面工程改造以展示RGD肽可提高其靶向效率和治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5767/4955065/b15d8f02011a/thnov06p1672g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5767/4955065/d07629d35d3e/thnov06p1672g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5767/4955065/3fe290a10994/thnov06p1672g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5767/4955065/0f2516d0b5c6/thnov06p1672g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5767/4955065/2146fa2c1f80/thnov06p1672g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5767/4955065/b15d8f02011a/thnov06p1672g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5767/4955065/d07629d35d3e/thnov06p1672g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5767/4955065/3fe290a10994/thnov06p1672g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5767/4955065/0f2516d0b5c6/thnov06p1672g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5767/4955065/2146fa2c1f80/thnov06p1672g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5767/4955065/b15d8f02011a/thnov06p1672g005.jpg

相似文献

1
RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy.RGD肽细胞表面展示增强减毒沙门氏菌介导的癌症治疗的靶向性和治疗效果。
Theranostics. 2016 Jun 20;6(10):1672-82. doi: 10.7150/thno.16135. eCollection 2016.
2
Attenuated Salmonella Typhimurium with truncated LPS and outer membrane-displayed RGD peptide for cancer therapy.用于癌症治疗的具有截短脂多糖和外膜展示RGD肽的减毒鼠伤寒沙门氏菌。
Biomed Pharmacother. 2022 Nov;155:113682. doi: 10.1016/j.biopha.2022.113682. Epub 2022 Sep 12.
3
RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.RGD 修饰的固体脂质纳米粒抑制 αvβ3 整合素过表达乳腺癌细胞的黏附和侵袭。
Drug Deliv Transl Res. 2015 Feb;5(1):15-26. doi: 10.1007/s13346-014-0210-2.
4
Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.通过电荷修饰和整合素 αvβ3 同源结构域的掺入,设计具有改进的抗肿瘤功效的α-螺旋肽 temporin-La 的合成类似物。
J Pept Sci. 2012 Jul;18(7):476-86. doi: 10.1002/psc.2420. Epub 2012 May 28.
5
RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.RGD与整合素αvβ3的结合影响原发性人乳腺癌培养物中的细胞运动性和粘附。
Ultrastruct Pathol. 2012 Dec;36(6):387-99. doi: 10.3109/01913123.2012.681834. Epub 2012 Nov 26.
6
Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.朝着开发一种用于治疗人类转移性黑色素瘤的新型非RGD环肽药物偶联物的方向发展。
Oncotarget. 2017 Jan 3;8(1):757-768. doi: 10.18632/oncotarget.12748.
7
RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.RGD 肽修饰的多功能树枝状大分子平台用于药物包封和靶向抑制癌细胞。
Colloids Surf B Biointerfaces. 2015 Jan 1;125:82-9. doi: 10.1016/j.colsurfb.2014.11.004. Epub 2014 Nov 11.
8
Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.利用携带突变型单纯疱疹病毒1型胸苷激酶PET报告基因的成像技术,对在活体小鼠中靶向表达整合素αvβ3的肿瘤的化学修饰腺病毒进行成像。
J Nucl Med. 2006 Jan;47(1):130-9.
9
Preparation and functional evaluation of RGD-modified streptavidin targeting to integrin-expressing melanoma cells.RGD 修饰的链霉亲和素的制备及其对整合素表达的黑色素瘤细胞的靶向功能评价。
Protein Eng Des Sel. 2013 Feb;26(2):143-50. doi: 10.1093/protein/gzs076. Epub 2012 Nov 16.
10
Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.通过与含RGD肽偶联将铂(IV)前药靶向递送至癌细胞。
Dalton Trans. 2015 Jan 7;44(1):202-12. doi: 10.1039/c4dt02710h.

引用本文的文献

1
Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives.用于疫苗开发的生物工程外膜囊泡:策略、进展与展望
Vaccines (Basel). 2025 Jul 20;13(7):767. doi: 10.3390/vaccines13070767.
2
Genetically-engineered Salmonella typhimurium expressing FGF21 promotes neurological recovery in ischemic stroke via FGFR1/AMPK/mTOR pathway.表达FGF21的基因工程鼠伤寒沙门氏菌通过FGFR1/AMPK/mTOR途径促进缺血性中风后的神经功能恢复。
J Neuroinflammation. 2025 Jun 28;22(1):170. doi: 10.1186/s12974-025-03498-0.
3
Engineered bacteria: Strategies and applications in cancer immunotherapy.

本文引用的文献

1
Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β.鼠伤寒沙门氏菌通过促炎细胞因子白细胞介素-1β抑制肿瘤生长。
Theranostics. 2015 Oct 6;5(12):1328-42. doi: 10.7150/thno.11432. eCollection 2015.
2
Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy.减毒鼠伤寒沙门氏菌在细菌介导的癌症治疗中对炎性小体的激活作用。
Microbiol Immunol. 2015 Nov;59(11):664-75. doi: 10.1111/1348-0421.12333.
3
Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent.
工程菌:癌症免疫治疗中的策略与应用
Fundam Res. 2024 Nov 13;5(3):1327-1345. doi: 10.1016/j.fmre.2024.11.001. eCollection 2025 May.
4
Oncolytic bacteria: A revolutionary approach to cancer therapy.溶瘤细菌:癌症治疗的革命性方法。
Open Life Sci. 2025 Jun 10;20(1):20251076. doi: 10.1515/biol-2025-1076. eCollection 2025.
5
Designing live bacterial therapeutics for cancer.设计用于癌症治疗的活细菌疗法。
Adv Drug Deliv Rev. 2025 Jun;221:115579. doi: 10.1016/j.addr.2025.115579. Epub 2025 Apr 12.
6
Potential applications of engineered bacteria in disease diagnosis and treatment.工程菌在疾病诊断与治疗中的潜在应用。
Microbiome Res Rep. 2024 Dec 17;4(1):10. doi: 10.20517/mrr.2024.57. eCollection 2025.
7
When synthetic biology meets medicine.当合成生物学遇上医学。
Life Med. 2024 Mar 6;3(1):lnae010. doi: 10.1093/lifemedi/lnae010. eCollection 2024 Feb.
8
Programmable cancer treatments: Engineering biology approaches for living cures.可编程癌症治疗:用于活体治疗的工程生物学方法。
Eng Biol. 2024 May 31;8(2-3):31-40. doi: 10.1049/enb2.12032. eCollection 2024 Jun-Sep.
9
Bacterial live therapeutics for human diseases.用于人类疾病的细菌活体疗法。
Mol Syst Biol. 2024 Dec;20(12):1261-1281. doi: 10.1038/s44320-024-00067-0. Epub 2024 Oct 23.
10
Bacterial therapies at the interface of synthetic biology and nanomedicine.合成生物学与纳米医学交叉领域的细菌疗法。
Nat Rev Bioeng. 2024 Feb;2(2):120-135. doi: 10.1038/s44222-023-00119-4. Epub 2023 Oct 10.
工程菌用于可视化靶向递送细胞毒性抗癌剂。
Mol Ther. 2013 Nov;21(11):1985-95. doi: 10.1038/mt.2013.183. Epub 2013 Aug 7.
4
Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas.经工程改造表达靶向 CD20 抗体和药物转化酶的沙门氏菌可以根除人类淋巴瘤。
Blood. 2013 Aug 1;122(5):705-14. doi: 10.1182/blood-2012-12-474098. Epub 2013 Jun 4.
5
Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu-positive tumor cells.工程菌靶向递送转染基因至 HER2/neu 阳性肿瘤细胞。
Biotechnol Bioeng. 2011 Jul;108(7):1662-72. doi: 10.1002/bit.23095. Epub 2011 Feb 24.
6
Engineering the perfect (bacterial) cancer therapy.工程化完美(细菌)癌症疗法。
Nat Rev Cancer. 2010 Nov;10(11):785-94. doi: 10.1038/nrc2934. Epub 2010 Oct 14.
7
ppGpp-mediated stationary phase induction of the genes encoded by horizontally acquired pathogenicity islands and cob/pdu locus in Salmonella enterica serovar Typhimurium.ppGpp 介导的水平获得的致病性岛和 cob/pdu 基因在鼠伤寒沙门氏菌中的定殖诱导
J Microbiol. 2010 Feb;48(1):89-95. doi: 10.1007/s12275-009-0179-6. Epub 2010 Mar 11.
8
Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer.基因工程鼠伤寒沙门氏菌作为癌症的可成像治疗探针。
Cancer Res. 2010 Jan 1;70(1):18-23. doi: 10.1158/0008-5472.CAN-09-3453. Epub 2009 Dec 22.
9
Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium.携带目的基因的鼠伤寒沙门氏菌对脊髓神经胶质瘤的靶向治疗。
Cell Prolif. 2010 Feb;43(1):41-8. doi: 10.1111/j.1365-2184.2009.00652.x. Epub 2009 Nov 18.
10
Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice.基因工程改造的鼠伤寒沙门氏菌在裸鼠原位人胰腺癌模型中的疗效。
Anticancer Res. 2009 Jun;29(6):1873-8.